Zydus Pharmaceuticals (USA) Inc 2024-07-31 Health serious FDA
Health · FDA · Recall #FDA-D-0617-2024
Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count… Recall
Issued July 31, 2024 · Zydus Pharmaceuticals (USA) Inc
In July 2024, Zydus Pharmaceuticals (USA) Inc recalled the Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.
What you should do
- 1 Stop using Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Zydus Pharmaceuticals (USA) Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Zydus Pharmaceuticals (USA) Inc
- Category
- Health
- Recall date
- July 31, 2024
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0617-2024
- Made in
- United States
- Issuing agency
- FDA
In context
- Zydus Pharmaceuticals (USA) Inc has 31 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 737th Health recall we've logged in 2024.